Coloplast rises after in-line Q1, analysts point to positioning

Coloplast A/S

04/02/2025 08:47

** Coloplast's  COLOb.CO  shares rise 3.5% after its Q1
print comes in line with expectations, with analysts pointing to
sector-leading growth momentum 
    ** The Danish intimate healthcare equipment maker reiterates
its full-year EBIT margin and organic growth outlook, flagging
it will be H2-weighted
    ** J.P. Morgan says in a note it expected the shares to rise
on positioning 
    ** "Coloplast remains a key pick, thanks to every metric
being sector-leading, notably an already superior growth profile
set to accelerate even further," Jefferies says
    ** The broker adds that while investors were taken off guard
by two large deals since late 2021, the path to margin recovery
is clear as M&A dilution and inflation wear off
    ** The stock is among top risers on Europe's STOXX 600
 .STOXX  index

 (Reporting by Agata Rybska)
 ((gdansk.newsroom@thomsonreuters.com;))